Yu-Che Cheng, Marvin L Hsieh, Chen-Ju Lin, Cindy M C Chang, Ching-Ying Huang, Riley Puntney, Amy Wu Moy, Chien-Yu Ting, Darien Zhing Herr Chan, Martin W Nicholson, Po-Ju Lin, Hung-Chih Chen, Gina C Kim, Jianhua Zhang, Jennifer Coonen, Puja Basu, Heather A Simmons, Yen-Wen Liu, Timothy A Hacker, Timothy J Kamp, Patrick C H Hsieh
BACKGROUND: Remuscularization of the mammalian heart can be achieved after cell transplantation of human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes (CMs). However, several hurdles remain before implementation into clinical practice. Poor survival of the implanted cells is related to insufficient vascularization, and the potential for fatal arrhythmogenesis is associated with the fetal cell-like nature of immature CMs. METHODS: We generated 3 lines of hiPSC-derived endothelial cells (ECs) and hiPSC-CMs from 3 independent donors and tested hiPSC-CM sarcomeric length, gap junction protein, and calcium-handling ability in coculture with ECs...
September 21, 2023: Circulation